Josep Callizo, Allergan (R), Bayer Healthcare (R), Novartis (R);
Thomas Bertelmann, Alcon (F), Alcon (R), Alimera Science (F), Alimera Science (R), Allergan (F), Allergan (R), Bayer Healthcare (F), Bayer Healthcare (R), Novartis (F), Novartis (R);
Jessica Voegeler, Novartis (E);
Steffen Schmitz-Valckenberg, Alcon (C), Alcon (F), Allergan (F), Allergan (R), Bayer Healthcare (F), Bayer Healthcare (R), Carl Zeis MediTec (F), Formycon (F), Genentech/Roche (C), Genentech/Roche (F), Genentech/Roche (R), Heidelberg Engineering (F), Heidelberg Engineering (R), Novartis (C), Novartis (F), Optos (F);
Georg Spital, Allergan (R), Bayer Healthcare (R), Heidelberg Engineering (R), Novartis (F), Novartis (R), Pfizer (R);
Nicolas Feltgen, Alimera Science (F), Alimera Science (C), Alimera Science (R), Allergan (F), Allergan (R), Bayer Healthcare (F), Bayer Healthcare (R), Heidelberg Engineering (R), Novartis (F), Novartis (R), Pfizer (F), Roche/Genentech (F);
Sandra Liakopoulos, Allergan (R), Bayer Healthcare (R), Heidelberg Engineering (R), Novartis (C), Novartis (R);
Focke Ziemssen, Alcon (R), Alimera Science (C), Allergan (C), Allergan (R), Bayer Healthcare (C), Bayer Healthcare (R), Biogen (R), Boehringer-Ingelheim (C), Novartis (C), Novartis (R)